NEWS
Mesoblast hopes $65m raising will end cash flow ‘chatter’
MELBOURNE: Mesoblast chief executive Silviu Itescu says the biotech’s ability to raise $US45m ... read more
Lumos Diagnostics cash crisis looms as value tumbles 95pc
MELBOURNE: Melbourne-based medtech company Lumos Diagnostics is in danger of running out of ... read more
ResMed profit jumps after rival’s own goal
MELBOURNE: The supply chain crisis constraining sleep disorder and breathing devices company ResMed ... read more
